Defining and targeting mechanisms of pancreas cancer pathogenesis

Information

  • Research Project
  • 10246463
  • ApplicationId
    10246463
  • Core Project Number
    R50CA211425
  • Full Project Number
    5R50CA211425-05
  • Serial Number
    211425
  • FOA Number
    PAR-17-049
  • Sub Project Id
  • Project Start Date
    9/19/2017 - 6 years ago
  • Project End Date
    8/31/2022 - a year ago
  • Program Officer Name
    FORRY, SUZANNE L
  • Budget Start Date
    9/1/2021 - 2 years ago
  • Budget End Date
    8/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    05
  • Suffix
  • Award Notice Date
    8/30/2021 - 2 years ago

Defining and targeting mechanisms of pancreas cancer pathogenesis

Project Summary Dr. Martin Whittle is a senior scientist working in the laboratory of Dr. Sunil Hingorani at the Fred Hutchinson Cancer Research Center. Dr. Whittle?s training has provided him a strong foundation in the fields of molecular biology, cancer cell signaling, and tumor modeling in mice. This Research Specialist award will support Dr. Whittle?s effort on research projects central to the overall Hingorani Laboratory research program including the following three key projects: the complex pancreas cancer microenvironment and its contributions to disease pathogenesis and drug resistance; the immune reaction in PDA and development of effective immunotherapies; and the molecular underpinnings of the metastatic switch in pancreas cancer. Aside from performing vital experiments for each of these projects, Dr. Whittle further supports the Hingorani lab by training new technicians and postdoctoral fellows in fundamental and advanced laboratory techniques that are critical to the Hingorani research program, including genetic engineering, mouse model development and characterization, animal husbandry, surgical procedures and necropsies, primary tissue culture, histochemistry and immunohistology, genotyping PCR, qRT-PCR, western blotting, FACS, fluorescence microscopy, gene array, molecular cloning, ELISA, mass spectrometry and others.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R50
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
    79159
  • Indirect Cost Amount
    60161
  • Total Cost
    139320
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:139320\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZCA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    FRED HUTCHINSON CANCER RESEARCH CENTER
  • Organization Department
  • Organization DUNS
    078200995
  • Organization City
    SEATTLE
  • Organization State
    WA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    981094433
  • Organization District
    UNITED STATES